IntraVec: The higher education of cells

IntraVec Inc. foresees therapeutic solutions for cancer and infectious diseases that would eliminate surgery, recurrent drug and vaccine administrations, chemotherapy and radiation - interventions that often require protracted treatments and which IntraVec considers to have limited utility in remediating chronic disease.

The company, which is developing three genetic engineering therapeutic platforms and a gene screening process, started last August with seed capital from Wake Forest University and is operating as an incubator company under the auspices of university technology transfer company QED Technologies Ltd.

Read the full 837 word article

How to gain access

Continue reading with a
two-week free trial.